Although women make up a majority of the population and typically the majority of primary care providers patient panel, it is well established that many gender specific needs of women, such as menopause and sexual health, are neglected, in part due to lack of women’s health education in these areas. In today’s panel, 3 women’s health experts will discuss 3 women’s health cases that highlight current data and best practice for management of early menopause, GSM, and women known to carry a genetic mutation that elevates their risk of breast and ovarian cancer. 

Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 12/05/2020, and they are subject to change as new information is published.

Learning Objectives

  • Describe data from the Women’s Health Initiative (WHI) as we understand it in 2020 
  • Discuss evidence-based management of menopause with a specific focus on management of early menopause
  • Describe the pathophysiology of Genitourinary Syndrome of Menopause and discuss current guidelines for management
  • Discuss the use of contraception and risk reducing surgery in women who carry a hereditary cancer gene


Lisa Larkin, MD, FACP, NCMP

Founder and CEO
Ms. Medicine
Cleveland, OH

Sheryl A. Kingsberg, PhD

Chief, Division of Behavioral Medicine
Department of OB/GYN
MacDonald Women’s Hospital
University Hospitals Cleveland Medical Center
Professor, Departments of Reproductive Biology and Psychiatry
Case Western Reserve University  School of Medicine
Cleveland, OH

Holly Pederson, MD, NCMP

Director, Medical Breast Services
Associate Professor of Medicine, Cleveland Clinic
Cleveland, OH


The following relevant financial relationships have been disclosed by faculty.

Lisa Larkin, MD, FACP, NCMP, IF: Consulting for TherapeuticsMD, Radius Health, and Palatin Technologies. Speaker’s Bureau for TherapeuticsMD. 

Sheryl A. Kingsberg, PhD: Speaker’s Bureau for AMAG, TherapeuticsMD, and Palatin Technologies. Advisory Board for AMAG, Astellas, Dare, Ovoca, Sprout, Pfizer, Mitsubishi Tanaba NA, TherapeuticsMD, Materna Medical, and Strategic Science Technologies. Consulting for AMAG, Dare, Ovoca, Sprout, Pfizer, Mitsubishi Tanaba NA, TherapeuticsMD, Materna Medical, Madorra, Strategic Science, Lupin Technologies, Palatin Technologies, Viveve, and Field Trip. Services provided for promotional purposes (not for CME/CE services) for: Pfizer, TherapeuticsMD, Palatin Technologies, Lupin, AMAG, Dare, and Strategic Science Technologies. Contracted Research for Dare, Strategic Science Technologies, Palatin Technologies, TherapeuticsMD, and Pfizer. 

Holly J. Pederson MD, NCMP: Consultant for Myriad Genetics. 

Charles Vega, MD, FAAFP (moderator): No relevant financial relationships disclosed.     

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

CME/CE Information

AMA PRA Category 1 Credits

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Accreditation Statement

Pri-Med Institute is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number 040308.

Designation Statement

This program has been approved for 1.00 contact hour of continuing education, which includes 0.33 hour of pharmacology.

Instructions for Obtaining Credit

Once you have completed the activity, please click the "next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer 2 out of the 3 questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and have the opportunity to review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen. For PAs, the NCCPA accepts for Category 1 CME credit activities designated for AMA PRA Category 1 Credit.

MOC Credit Information

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.